TNDM Live signals | Maximize Profits with Getagraph.com

SELL 3559 min ago

@ $51.42

Issued: 31 May 2024 @ 15:13

Return: -0.37%

Previous signal: May 31 - 12:31

Previous signal: Buy

Return: -1.29 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.35% compare to its pairs and should correct upwards.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally...

Stats
Today's Volume	1.39M
Average Volume	1.81M
Market Cap	3.31B
EPS	$0 ( 2024-05-02 )
Next earnings date	( $-0.560 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-23.72
ATR14	$2.87 (5.61%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-28	Vosseller Leigh	Buy	406	Common Stock
2024-05-28	Vosseller Leigh	Sell	145	Common Stock
2024-05-23	Vosseller Leigh	Buy	17 946	Restricted Stock Unit
2024-05-23	Vosseller Leigh	Buy	17 946	Performance Stock Unit
2024-05-28	Vosseller Leigh	Sell	406	Restricted Stock Unit

INSIDER POWER
66.02
Last 100 transactions
Buy: 416 705 \| Sell: 85 615

Correlation (AI algo v.1.1b): Undervalued: 0.35% $51.34 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.45 (neutral)

Short: 0.28 (neutral)

Signal:(44) Neutral

Tandem Diabetes Care Inc Correlation

10 Most Positive Correlations
DINT	0.943
BNTC	0.933
VCTR	0.923
VITL	0.911
FUTU	0.908
AEYE	0.907
PUI	0.906
IBRX	0.899
APOG	0.899
LAUR	0.897

10 Most Negative Correlations
SYPR	-0.919
TOI	-0.912
PEV	-0.908
SAGE	-0.908
OPOF	-0.901
APDN	-0.898
VRSN	-0.897
ASNS	-0.883
AEI	-0.88
APLS	-0.88

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Tandem Diabetes Care Inc Correlation - Currency/Commodity

0.60
( weak )

0.54
( weak )

-0.54
( weak negative )

0.73
( moderate )

-0.29
( neutral )

Tandem Diabetes Care Inc Financials

Annual	2023
Revenue:	$747.72M
Gross Profit:	$367.69M (49.17 %)
EPS:	$-3.43

FY	2023
Revenue:	$747.72M
Gross Profit:	$367.69M (49.17 %)
EPS:	$-3.43

FY	2022
Revenue:	$801.22M
Gross Profit:	$412.99M (51.54 %)
EPS:	$-1.470

FY	2021
Revenue:	$702.80M
Gross Profit:	$376.22M (53.53 %)
EPS:	$0.260

Financial Reports:

No articles found.

Tandem Diabetes Care Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.